Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
33.35
+2.83 (9.27%)
Jun 29, 2026, 4:00 PM EDT - Market closed
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $552.62 million as of June 30, 2026. Its market cap has increased by 706.47% in one year.
Market Cap
552.62M
Enterprise Value
363.70M
1-Year Change
706.47%
Ranking
Category
Stock Price
$33.35
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $552.62M, an increase of 59.29%. That is a compound annual growth rate of 6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 552.62M | 460.64% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 528.60M |
| Rezolute | 526.51M |
| Prothena Corporation | 524.58M |
| Arvinas | 516.17M |
| Forte Biosciences | 513.88M |
| Kyverna Therapeutics | 513.11M |
| Zura Bio | 508.24M |
| Ocugen | 507.78M |